News for Healthier Living

CRISPR-Cas13: A New Frontier in RNA-Editing with Revolutionary Therapeutic Potential

A new review highlights the potential of CRISPR-Cas13 for RNA-editing therapies. Discussing the advantages of the effector protein Cas13 over Cas9, they report that CRISPR-Cas13 facilitates RNA knockdown, RNA silencing, RNA splicing, RNA-base editing, and translation regulation. CRISPR-Cas13 has diverse applications like virus detection, antivirus vaccines, and personalized therapies. Additionally, they also discuss the role of AI in enabling the realization of the full potential of RNA-editing technologies.

September 25, 2024


October 5 2024

October 4 2024

October 3 2024

October 2 2024

October 1 2024

September 30 2024

September 29 2024

September 28 2024

September 27 2024

September 26 2024

September 25 2024

September 24 2024

September 23 2024

September 22 2024

September 21 2024